10x Genomics (TXG) Operating Income (2018 - 2025)
Historic Operating Income for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$19.5 million.
- 10x Genomics' Operating Income rose 6079.17% to -$19.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$61.0 million, marking a year-over-year increase of 6865.48%. This contributed to the annual value of -$61.0 million for FY2025, which is 6865.48% up from last year.
- Per 10x Genomics' latest filing, its Operating Income stood at -$19.5 million for Q4 2025, which was up 6079.17% from -$32.2 million recorded in Q3 2025.
- 10x Genomics' 5-year Operating Income high stood at $30.1 million for Q2 2025, and its period low was -$94.8 million during Q3 2023.
- Moreover, its 5-year median value for Operating Income was -$40.7 million (2022), whereas its average is -$37.1 million.
- Per our database at Business Quant, 10x Genomics' Operating Income crashed by 51112.51% in 2022 and then soared by 17218.06% in 2025.
- Quarter analysis of 5 years shows 10x Genomics' Operating Income stood at -$15.8 million in 2021, then plummeted by 45.9% to -$23.1 million in 2022, then crashed by 138.95% to -$55.2 million in 2023, then rose by 9.69% to -$49.8 million in 2024, then surged by 60.79% to -$19.5 million in 2025.
- Its last three reported values are -$19.5 million in Q4 2025, -$32.2 million for Q3 2025, and $30.1 million during Q2 2025.